Haylee Brown

Associate

Haylee Brown

New York

+1 917 229 7553

Haylee Brown is an associate in the firm’s Business Law department and a member of its nationally recognized Life Sciences group. Haylee’s practice covers all phases of the corporate life cycle, including venture financings and initial public offerings, with a focus on representing both public companies and investment banks in connection with a variety of capital markets transactions. Haylee also counsels clients on ongoing securities law compliance and corporate governance matters.

Experience

Avalyn Pharma in its $345 million initial public offering
Placement agents in Valneva SE’s €84 million private placement of ordinary shares and warrants
The underwriters and sales agent of Sera Prognostics’ $50 million follow-on public offering and $50 million at-the-market offering program, respectively
Underwriters in VSE Corp’s upsized $1.3 billion common stock and tangible equity unit offerings
Initial purchasers in Bitdeer Technologies Group’s upsized $375 million convertible senior notes offering with a capped call and registered direct offering
Initial purchasers in Bitdeer Technologies Group’s upsized $375 million 4.875% convertible senior notes offering
Agents in Bitdeer Technologies Group’s $1.0 billion at-the-market offering of Class A ordinary shares
Placement agent in SCHMID Group N.V.’s $30 million private placement of convertible notes and warrants to purchase ordinary shares
Underwriters in Lineage, Inc.’s $5.1 billion initial public offering
Scholar Rock Holding Corporation in its $300 million follow-on offering
Underwriters in The Pennant Group’s $124.7 million public offering
Underwriters in scPharmaceuticals’ $50 million follow-on public offering
Underwriters in Aileron Therapeutics’ $20 million registered direct offering
Initial purchasers and dealers in Enovis Corporation’s $460 million 3.875% convertible senior notes offering and capped call
Arrowroot Capital Acquisition Corp. in its business combination with iLearningEngines
Prime Medicine in its $300 million at-the-market offering, $161 million follow-on offering, and its $3.5 billion global collaboration and $55 million equity investment with Bristol-Myers Squibb
Underwriters in PACS Group’s $517 million upsized initial public offering and $690 million upsized primary and secondary follow-on offering
Underwriters and/or agents in connection with multiple follow-on offerings of more than $300 million and a $212 million at-the-market program for Taysha Gene Therapies
Amylyx Pharmaceuticals in its $200 million underwritten public offering
Underwriters in Inotiv’s $26 million follow-on public offering and agent in Inotiv’s $50 million at-the-market offering of common stock
Olink Proteomics in its $80.75 million follow-on offering

Professional experience

Haylee was previously on a client secondment at TD Securities (USA) LLC, where she advised on equity and equity-linked capital markets transactions.

Haylee was a summer associate at Goodwin in 2021. During law school, she participated in the Health and Disability Law Clinic and was an editorial board member of the Journal of Law & Politics.

Haylee Brown

Experience

Professional experience

Credentials

Education

JD2022

BS2018

Admissions

Bars

Related Content

Goodwin Advises Jefferies, TD Cowen, Stifel and Van Lanschot Kempen in Connection With €84 Million Private Placement of Valneva SE

Goodwin Guides Avalyn on Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for a Total of $345 Million

Goodwin Advises Obsidian Therapeutics on Merger With Galera Therapeutics and $350 Million Private Placement Financing

Goodwin Advises on Bitdeer’s Upsized $375 Million Convertible Senior Notes Offering With Capped Call and Registered Direct Offering

Goodwin Guides Banks in VSE Corp’s Upsized $1.3 Billion Common Stock and Tangible Equity Unit Offerings to Finance Acquisition

Goodwin Advises Prime Medicine on $144.2 Million Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Goodwin Represents the Initial Purchasers on Bitdeer’s Upsized $375 Million 4.875% Convertible Senior Notes Offering

Goodwin Represents the Initial Purchasers on Bitdeer’s $400 Million 5.25% Convertible Senior Notes Offering

Life Sciences

Haylee Brown

Experience

Capital Markets Transactions

Venture Capital Financings

Professional experience

Credentials

Education

JD2022

BS2018

Admissions

Bars

Related Content

Goodwin Advises Jefferies, TD Cowen, Stifel and Van Lanschot Kempen in Connection With €84 Million Private Placement of Valneva SE

Goodwin Guides Avalyn on Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for a Total of $345 Million

Goodwin Advises Obsidian Therapeutics on Merger With Galera Therapeutics and $350 Million Private Placement Financing

Goodwin Advises on Bitdeer’s Upsized $375 Million Convertible Senior Notes Offering With Capped Call and Registered Direct Offering

Goodwin Guides Banks in VSE Corp’s Upsized $1.3 Billion Common Stock and Tangible Equity Unit Offerings to Finance Acquisition

Goodwin Advises Prime Medicine on $144.2 Million Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Goodwin Represents the Initial Purchasers on Bitdeer’s Upsized $375 Million 4.875% Convertible Senior Notes Offering

Goodwin Represents the Initial Purchasers on Bitdeer’s $400 Million 5.25% Convertible Senior Notes Offering